IFG Advisory LLC Has $474,000 Holdings in Welltower Inc (WELL)

Share on StockTwits

IFG Advisory LLC increased its position in Welltower Inc (NYSE:WELL) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 6,118 shares of the real estate investment trust’s stock after acquiring an additional 567 shares during the period. IFG Advisory LLC’s holdings in Welltower were worth $474,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Rational Advisors LLC lifted its holdings in shares of Welltower by 4,166.4% in the first quarter. Rational Advisors LLC now owns 37,459 shares of the real estate investment trust’s stock valued at $2,906,000 after buying an additional 36,581 shares during the period. Piedmont Investment Advisors Inc. lifted its holdings in shares of Welltower by 11.5% in the first quarter. Piedmont Investment Advisors Inc. now owns 6,226 shares of the real estate investment trust’s stock valued at $483,000 after buying an additional 643 shares during the period. Barings LLC raised its position in shares of Welltower by 22.3% during the first quarter. Barings LLC now owns 962,163 shares of the real estate investment trust’s stock worth $74,664,000 after purchasing an additional 175,221 shares during the period. Penserra Capital Management LLC acquired a new stake in shares of Welltower during the first quarter worth $93,000. Finally, Great West Life Assurance Co. Can raised its position in shares of Welltower by 16.8% during the first quarter. Great West Life Assurance Co. Can now owns 587,531 shares of the real estate investment trust’s stock worth $45,534,000 after purchasing an additional 84,442 shares during the period. Institutional investors and hedge funds own 84.46% of the company’s stock.

NYSE:WELL opened at $81.57 on Friday. The firm has a market cap of $32.40 billion, a P/E ratio of 20.24, a price-to-earnings-growth ratio of 3.37 and a beta of 0.43. Welltower Inc has a 1-year low of $56.11 and a 1-year high of $81.92. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.79.

Welltower (NYSE:WELL) last posted its quarterly earnings results on Tuesday, April 30th. The real estate investment trust reported $1.02 earnings per share for the quarter, meeting the consensus estimate of $1.02. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.24 billion. Welltower had a return on equity of 4.97% and a net margin of 13.06%. Welltower’s quarterly revenue was up 16.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.99 earnings per share. Equities research analysts predict that Welltower Inc will post 4.2 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 28th. Investors of record on Tuesday, May 14th will be given a dividend of $0.87 per share. This represents a $3.48 annualized dividend and a yield of 4.27%. The ex-dividend date of this dividend is Monday, May 13th. Welltower’s payout ratio is 86.35%.

In other Welltower news, EVP Mercedes Kerr sold 5,000 shares of the company’s stock in a transaction dated Thursday, February 28th. The stock was sold at an average price of $74.50, for a total value of $372,500.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Thomas J. Derosa sold 19,307 shares of the company’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $77.90, for a total value of $1,504,015.30. The disclosure for this sale can be found here. 0.15% of the stock is currently owned by insiders.

A number of equities research analysts have recently issued reports on the company. BMO Capital Markets reaffirmed a “hold” rating and set a $73.00 target price on shares of Welltower in a research report on Wednesday, May 1st. Raymond James boosted their target price on Welltower from $75.00 to $78.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 26th. They noted that the move was a valuation call. Mitsubishi UFJ Financial Group boosted their target price on Welltower to $82.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 13th. Deutsche Bank boosted their target price on Welltower from $61.00 to $71.00 and gave the stock a “hold” rating in a research report on Friday, March 29th. Finally, Citigroup boosted their target price on Welltower from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Thursday, February 14th. Seven investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Welltower presently has a consensus rating of “Buy” and a consensus target price of $73.29.

ILLEGAL ACTIVITY NOTICE: This report was posted by BBNS and is the sole property of of BBNS. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://baseballnewssource.com/2019/05/25/ifg-advisory-llc-has-474000-holdings-in-welltower-inc-well/3412984.html.

Welltower Profile

Welltower Inc (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

Recommended Story: Gross Domestic Product (GDP)

Want to see what other hedge funds are holding WELL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Welltower Inc (NYSE:WELL).

Institutional Ownership by Quarter for Welltower (NYSE:WELL)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.